Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Clinical trial NCT05802836 · RECRUITING

Trial details

NCT number: NCT05802836
Sponsor: Christoph Königs
Status: RECRUITING
Study type: OBSERVATIONAL

Severe Hemophilia A Severe Hemophilia A With Inhibitor Severe Hemophilia A Without Inhibitor

Start date: 2023-04-26
Primary completion: 2028-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.